相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target
Gabriel J. Villares et al.
Oncotarget (2015)
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance
Karla C. S. Queiroz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling
Susanne A. Kuhn et al.
NEUROLOGICAL RESEARCH (2014)
Comparative Expression Study of the Endo-G Protein Coupled Receptor (GPCR) Repertoire in Human Glioblastoma Cancer Stem-like Cells, U87-MG Cells and Non Malignant Cells of Neural Origin Unveils New Potential Therapeutic Targets
Marie Feve et al.
PLOS ONE (2014)
Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions
Nicole Baeumer et al.
PLOS ONE (2014)
Prevalence and Clinicopathologic Characteristics of the Molecular Subtypes in Malignant Glioma: A Multi-Institutional Analysis of 941 Cases
Ning Lin et al.
PLOS ONE (2014)
Biased signaling of protease-activated receptors
Peishen Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact
Frank Gieseler et al.
CELL COMMUNICATION AND SIGNALING (2013)
An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway
Huang Guo et al.
JOURNAL OF NEUROSCIENCE (2013)
Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype
N. Magnus et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Transcriptional Differences between Normal and Glioma-Derived Glial Progenitor Cells Identify a Core Set of Dysregulated Genes
Romane M. Auvergne et al.
CELL REPORTS (2013)
The Association of Protease Activated Receptor 1 gene-506 I/D Polymorphism with Disease-Free Survival in Breast Cancer Patients
Aydan Eroglu et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Effect of cancer therapy on neural stem cells: implications for cognitive function
Erin Gibson et al.
CURRENT OPINION IN ONCOLOGY (2012)
Targeting proteinase-activated receptors: therapeutic potential and challenges
Rithwik Ramachandran et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Thromboembolic disease in patients with high-grade glioma
James R. Perry
NEURO-ONCOLOGY (2012)
Direct thrombin inhibitors
Catherine J. Lee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis
Maya Zigler et al.
CANCER RESEARCH (2011)
Cancer Stem Cells in Gliomas: Identifying and Understanding the Apex Cell in Cancer's Hierarchy
Monica Venere et al.
GLIA (2011)
PAR1 Plays a Role in Epithelial Malignancies: Transcriptional Regulation and Novel Signaling Pathway
Rachel Bar-Shavit et al.
IUBMB LIFE (2011)
Correlation Between MMP1-PAR1 Axis and Clinical Outcome of Primary Gallbladder Carcinoma
Xilin Du et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas
Yan Zhang et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Structure, function and pathophysiology of protease activated receptors
Mark N. Adams et al.
PHARMACOLOGY & THERAPEUTICS (2011)
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Aurelie Tchoghandjian et al.
BRAIN PATHOLOGY (2010)
Signal transduction by protease-activated receptors
Unice J. K. Soh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Use of dabigatran etexilate to reduce breast cancer progression
Karen Defeo et al.
CANCER BIOLOGY & THERAPY (2010)
Non-Stem Cell Origin for Oligodendroglioma
Anders I. Persson et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Thrombin-Activated Receptors: Promising Targets for Cancer Therapy?
M. T. Garcia-Lopez et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer
Andrea Pia Elste et al.
JOURNAL OF MOLECULAR HISTOLOGY (2010)
Role of the tissue factor pathway in the biology of tumor initiating cells
Delphine Garnier et al.
THROMBOSIS RESEARCH (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Tissue Factor and Cancer Stem Cells Is There a Linkage?
Chloe Milsom et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
Joachim Stangier
CLINICAL PHARMACOKINETICS (2008)
Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas
Alfred T. Ogden et al.
NEUROSURGERY (2008)
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
P. Arora et al.
ONCOGENE (2008)
I/NI-calls for the exclusion of non-informative genes:: a highly effective filtering tool for microarray data
Willem Talloen et al.
BIOINFORMATICS (2007)
Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1
Nikos E. Tsopanoglou et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: Association with endothelial cell growth suppression and induction of apoptosis
Panagiota Zania et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer
Paulo Ghio et al.
CLINICAL LUNG CANCER (2006)
Protease-activated receptors in hemostasis, thrombosis and vascular biology
SR Coughlin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma
D Massi et al.
HUMAN PATHOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma
DJ Brat et al.
LABORATORY INVESTIGATION (2004)
Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes
CE Junge et al.
EXPERIMENTAL NEUROLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain
MC Nunes et al.
NATURE MEDICINE (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
分享论文
